Micro-environment causes reversible changes in DNA methylation and mRNA expression profiles in patient-derived glioma stem cells

PLoS ONE

Volumn 9, Issue 4, 2014, Pages

  Baysan, Mehmet ^a   Woolard, Kevin ^b   Bozdag, Serdar ^c   Riddick, Gregory ^d   Kotliarova, Svetlana ^d   Cam, Margaret C ^d   Belova, Galina I ^d   Ahn, Susie ^d   Zhang, Wei ^d   Song, Hua ^d   Walling, Jennifer ^d   Stevenson, Holly ^d   Meltzer, Paul ^d   Fine, Howard A ^a  

^a NEW YORK UNIVERSITY MEDICAL CENTER   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c MARQUETTE UNIVERSITY   (United States)

^d NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GENOMIC DNA; MESSENGER RNA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER STEM CELL; CONTROLLED STUDY; DNA METHYLATION; FEMALE; GENE EXPRESSION; GLIOMA; GLIOMA STEM CELL; HUMAN; HUMAN TISSUE; MOUSE; NONHUMAN; TRANSCRIPTOMICS; TUMOR MICROENVIRONMENT; TUMOR XENOGRAFT; ANIMAL; GENETICS; IN VITRO STUDY; METABOLISM; PHYSIOLOGY; PRINCIPAL COMPONENT ANALYSIS; PROSPECTIVE STUDY; SCID MOUSE; SINGLE NUCLEOTIDE POLYMORPHISM; TUMOR CELL CULTURE;

ANIMALS; DNA METHYLATION; FEMALE; GLIOMA; HUMANS; IN VITRO TECHNIQUES; MICE; MICE, SCID; NEOPLASTIC STEM CELLS; POLYMORPHISM, SINGLE NUCLEOTIDE; PRINCIPAL COMPONENT ANALYSIS; PROSPECTIVE STUDIES; TUMOR CELLS, CULTURED;

EID: 84899653917     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0094045     Document Type: Article

References (35)

1. Chen J, McKay RM, Parada LF (2012) Malignant glioma: lessons from genomics, mouse models, and stem cells. Cell 149: 36-47.
2. Jones TS, Holland EC (2011) Animal models for glioma drug discovery. Expert Opinion on Drug Discovery 6: 1271-1283.
3. Bhat KP, Balasubramaniyan V, Vaillant B, Ezhilarasan R, Hummelink K, et al. (2013) Mesenchymal differentiation mediated by NF-kB promotes radiation resistance in glioblastoma. Cancer cell 24: 331-346.
4. Soda Y, Marumoto T, Friedmann-Morvinski D, Soda M, Liu F, et al. (2011) Transdifferentiation of glioblastoma cells into vascular endothelial cells. Proceedings of the National Academy of Sciences 108: 4274-4280.
5. Singh D, Chan JM, Zoppoli P, Niola F, Sullivan R, et al. (2012) Transforming fusions of FGFR and TACC genes in human glioblastoma. Science 337: 1231-1235.
6. Denysenko T, Gennero L, Roos MA, Melcarne A, Juenemann C, et al. (2010) Glioblastoma cancer stem cells: heterogeneity, microenvironment and related therapeutic strategies. Cell biochemistry and function 28: 343-351.
7. Sung KE, Yang N, Pehlke C, Keely PJ, Eliceiri KW, et al. (2011) Transition to invasion in breast cancer: a microfluidic in vitro model enables examination of spatial and temporal effects. Integrative Biology 3: 439-450.
8. Beroukhim R, Getz G, Nghiemphu L, Barretina J, Hsueh T, et al. (2007) Assessing the significance of chromosomal aberrations in cancer: methodology and application to glioma. Proceedings of the National Academy of Sciences 104: 20007-20012.
9. Brennan CW, Verhaak RG, McKenna A, Campos B, Noushmehr H, et al. (2013) The somatic genomic landscape of glioblastoma. Cell 155: 462-477.
10. Frattini V, Trifonov V, Chan JM, Castano A, Lia M, et al. (2013) The integrated landscape of driver genomic alterations in glioblastoma. Nature genetics 45: 1141-1149.
11. Szerlip NJ, Pedraza A, Chakravarty D, Azim M, McGuire J, et al. (2012) Intratumoral heterogeneity of receptor tyrosine kinases EGFR and PDGFRA amplification in glioblastoma defines subpopulations with distinct growth factor response. Proceedings of the National Academy of Sciences 109: 3041-3046.
12. Noushmehr H, Weisenberger DJ, Diefes K, Phillips HS, Pujara K, et al. (2010) Identification of a CpG Island Methylator Phenotype that Defines a Distinct Subgroup of Glioma. Cancer Cell 17: 510-522.
13. Duncan CG, Barwick BG, Jin G, Rago C, Kapoor-Vazirani P, et al. (2012) A heterozygous IDH1R132H/WT mutation induces genome-wide alterations in DNA methylation. Genome research 22: 2339-2355.
14. Turcan S, Rohle D, Goenka A, Walsh LA, Fang F, et al. (2012) IDH1 mutation is sufficient to establish the glioma hypermethylator phenotype. Nature.
15. Bozdag S, Li A, Riddick G, Kotliarov Y, Baysan M, et al. (2013) Age-specific signatures of glioblastoma at the genomic, genetic, and epigenetic levels. PloS one 8: e62982.
16. Ene CI, Edwards L, Riddick G, Baysan M, Woolard K, et al. (2012) Histone demethylase Jumonji D3 (JMJD3) as a tumor suppressor by regulating p53 protein nuclear stabilization. PloS one 7: e51407.
17. Li A, Walling J, Ahn S, Kotliarov Y, Su Q, et al. (2009) Unsupervised analysis of transcriptomic profiles reveals six glioma subtypes. Cancer Research 69: 2091-2099.
18. Gonda DD, Cheung VJ, Muller KA, Goyal A, Carter BS, et al. (2013) The Cancer Genome Atlas expression profiles of low-grade gliomas.
19. Verhaak RGW, Hoadley KA, Purdom E, Wang V, Qi Y, et al. (2010) Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1. Cancer cell 17: 98-110.
20. Sumazin P, Yang X, Chiu H-S, Chung W-J, Iyer A, et al. (2011) An extensive microRNA-mediated network of RNA-RNA interactions regulates established oncogenic pathways in glioblastoma. Cell 147: 370-381.
21. Lee J, Kotliarova S, Kotliarov Y, Li A, Su Q, et al. (2006) Tumor stem cells derived from glioblastomas cultured in bFGF and EGF more closely mirror the phenotype and genotype of primary tumors than do serum-cultured cell lines. Cancer Cell 9: 391-403.
22. Chen J, Li Y, Yu T-S, McKay RM, Burns DK, et al. (2012) A restricted cell population propagates glioblastoma growth after chemotherapy. Nature 488: 522-526.
23. Ricci-Vitiani L, Pallini R, Biffoni M, Todaro M, Invernici G, et al. (2010) Tumour vascularization via endothelial differentiation of glioblastoma stem-like cells. Nature 468: 824-828.
24. Bonavia R, Mukasa A, Narita Y, Sah DW, Vandenberg S, et al. (2010) Tumor heterogeneity is an active process maintained by a mutant EGFR-induced cytokine circuit in glioblastoma. Genes & development 24: 1731-1745.
25. Persano L, Rampazzo E, Basso G, Viola G (2013) Glioblastoma cancer stem cells: role of the microenvironment and therapeutic targeting. Biochemical pharmacology 85: 612-622.
26. Kleihues P, Louis DN, Scheithauer BW, Rorke LB, Reifenberger G, et al. (2002) The WHO classification of tumors of the nervous system. Journal of Neuropathology & Experimental Neurology 61: 215-225.
27. Baysan M, Bozdag S, Cam MC, Kotliarova S, Ahn S, et al. (2012) G-Cimp Status Prediction Of Glioblastoma Samples Using mRNA Expression Data. PloS ONE 7: e47839.
28. Bibikova M, Barnes B, Tsan C, Ho V, Klotzle B, et al. (2011) High density DNA methylation array with single CpG site resolution. Genomics 98: 288-295.
29. Dedeurwaerder S, Defrance M, Calonne E, Denis H, Sotiriou C, et al. (2011) Evaluation of the Infinium Methylation 450K technology. Epigenomics 3: 771-784.
30. Nazor KL, Altun G, Lynch C, Tran H, Harness JV, et al. (2012) Recurrent variations in DNA methylation in human pluripotent stem cells and their differentiated derivatives. Cell Stem Cell 10: 620-634.
31. Bork S, Pfister S, Witt H, Horn P, Korn B, et al. (2010) DNA methylation pattern changes upon long-term culture and aging of human mesenchymal stromal cells. Aging Cell 9: 54-63.
32. Meissner A, Mikkelsen TS, Gu H, Wernig M, Hanna J, et al. (2008) Genomescale DNA methylation maps of pluripotent and differentiated cells. Nature 454: 766-770.
33. Ashburner M, Ball CA, Blake JA, Botstein D, Butler H, et al. (2000) Gene Ontology: tool for the unification of biology. Nature Genetics 25: 25.
34. Zhao Q, Rank G, Tan YT, Li H, Moritz RL, et al. (2009) PRMT5-mediated methylation of histone H4R3 recruits DNMT3A, coupling histone and DNA methylation in gene silencing. Nature Structural & Molecular Biology 16: 304-311.
35. Kim HS, Woolard K, Lai C, Bauer PO, Maric D, et al. (2012) Gliomagenesis arising from Pten-and Ink4a/Arf-deficient neural progenitor cells is mediated by the p53-Fbxw7/Cdc4 pathway, which controls c-Myc. Cancer Research 72: 6065-6075.